Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Putting Patients First - KCR’s Contribution to Patient-Centric Approach in Clinical Trials

    Sep 20, 2017, 06:53 AM by Michael Croft
    BERLIN, GERMANY - Sep 20, 2017 - Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber
    Full story
  • Edico Genome’s DRAGEN Now Available On Illumina’s BaseSpace Sequence Hub

    Sep 19, 2017, 11:35 AM by Michael Croft

    Bio-IT World Brief | Edico Genome today announced the availability of its DRAGEN Bio-IT Platform on Illumina’s BaseSpace Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data.

    Full story
  • HighRes and Titian drive pharma operational efficiency through robotics and inventory logistics

    Sep 19, 2017, 08:28 AM by Michael Croft
    LONDON, UK - Sep 19, 2017 - HighRes and Titian drive pharma operational efficiency through robotics and inventory logisticsTheir combined flexible automation and sample tracking system delivers significant savings by reducing compound management protocols at major pharma companiesx
    Full story
  • Amazon Announces Per-Second Billing For EC2 Instances And EBS Volumes

    Sep 18, 2017, 14:00 PM by Michael Croft

    AWS Blog | Amazon has announced that, effective October 2, usage of Linux instances that are launched in On-Demand, Reserved, and Spot form will be billed in one-second increments. Similarly, provisioned storage for EBS volumes will be billed in one-second increments. Per-second billing also applies to Amazon EMR and AWS Batch.

    Full story
  • Cenduit to Discuss Advanced Solutions at Clinical Trial Supply Chain Europe

    Sep 18, 2017, 12:06 PM by Michael Croft
    DURHAM, NC, UNITED STATES - Sep 18, 2017 -  WHAT:  Cenduit LLC, the largest interactive response technology (IRT) specialist in the world, will be attending the Clinical Trial Supply Chain Europe meeting, September 26 in Zurich, Switzerland
    Full story
  • Boris Johnson stresses ‘importance of the life sciences sector to the UK economy’ at TraceLink’s new European HQ launch

    Sep 18, 2017, 12:05 PM by Michael Croft
    UXBRIDGE, UK - Sep 18, 2017 - Foreign Secretary Boris Johnson has officially opened TraceLink’s new European headquarters in Uxbridge, UK
    Full story
  • Tjoapack invests in bottle packing capabilities

    Sep 18, 2017, 12:00 PM by Michael Croft
    EARREN-LEUR, NETHERLANDS - Sep 18, 2017 - A Dutch contract packaging organisation (CPO) has strengthened its bottle filling capacity with a major investment
    Full story
  • Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision Medicine

    Sep 18, 2017, 10:26 AM by Michael Croft
    SAN FRANCISCO, CA, UNITED STATES - Sep 18, 2017 - Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision MedicineSan Francisco, CA - September 18, 2017Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing investor Data Collective (DCVC) and new investor Ascension Ventures, and participation from existing and new investors iSelect, Y Combinator, Wilson Sonsini Goodrich & Rosati, and Stanford
    Full story
  • Earlham Institute Presents Sequence Alignment Using Optalysys’ Optical Correlator Computing System

    Sep 18, 2017, 09:35 AM by Michael Croft

    Bio-IT World | 2017 Best Practices Awards | The Earlham Institute are working with Optalysys to apply Optalysys’ optical computing system to life science applications. The first release of the computing system is scheduled for early 2018, which both organizations say will be capable of performing a number of different DNA-based local sequence alignment applications.

    Full story
  • Demand for genetic testing drives growth for award winning Elucigene diagnostics

    Sep 15, 2017, 04:47 AM by Michael Croft
    MANCHESTER, UNITED KINGDOM - Sep 15, 2017 - Having the right technology at the right time has made Elucigene Diagnostics a world leading developer and distributor of prenatal, rare disease and infertility genetics diagnostics
    Full story
  • Oxford Genetics Supports Significant Growth with New U.S. Office

    Sep 14, 2017, 14:54 PM by Michael Croft
    BOSTON, MA, UNITED STATES - Sep 12, 2017 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has announced that it has opened its first U
    Full story
  • Recipharm and Kancera collaborate to manufacture clinical trial supply

    Sep 14, 2017, 14:48 PM by Michael Croft
    SOLNA, SWEDEN - Sep 14, 2017 - Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed a contract for the development and manufacture of the pharmaceutical candidate KAND567
    Full story
  • Moderna Ends “Venture” Experiment, Dissolves Four Startups

    Sep 14, 2017, 10:03 AM by Michael Croft
    Xconomy | Moderna Therapeutics announced today that it is ending the experiment to hatch startups as wholly-owned subsidaries, bringing all their experimental drugs back into the Moderna nest.
    Full story
  • Kyowa Hakko Kirin Joins Certara’s Simcyp Consortium

    Sep 13, 2017, 09:22 AM by Michael Croft
    PRINCETON, NJ - Sep 13, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that Kyowa Hakko Kirin Co
    Full story
  • Brainin Joins WuXi NextCODE, Prioritizes Actionability Of Genome

    Sep 13, 2017, 09:00 AM by Michael Croft

    Bio-IT World | WuXi NextCODE today announced the appointment of Rob Brainin as executive vice president and chief operating officer. Brainin joins the company from Illumina, where he was vice president and general manager of life sciences and applied genomics.

    Full story
  • BC Platforms Launches Unique Global Genomics and Clinical Data Analytics Resource

    Sep 13, 2017, 02:12 AM by Michael Croft
    BASEL, SWITZERLAND - Sep 13, 2017 -  BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data
    Full story
  • Maine Technology Institute Funds MDI Biological Laboratory Scientist

    Sep 12, 2017, 16:11 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Sep 12, 2017 - The Maine Technology Institute (MTI) has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans
    Full story
  • IBM Expands Certified Public Cloud Infrastructure For SAP HANA

    Sep 12, 2017, 11:05 AM by Michael Croft

    Bio-IT World Brief | IBM today announced the availability of new SAP-certified bare metal servers for SAP HANA platform deployments in the IBM Cloud and new configurations for VMware environments. The new cloud infrastructure-as-a-service solutions are designed to give enterprises the power and performance they need to manage their mission-critical applications running on SAP HANA.

    Full story
  • Repositive Joins Campaign to Support Rare Disease

    Sep 12, 2017, 10:22 AM by Michael Croft
    CAMBRIDGE, UK - Sep 12, 2017 - ... Repositive, the company that created the world’s largest portal for accessing human genomic research data is using its data platform, community and influence to help Maddie Thurgood, a young girl from the UK with the rare disease, Spastic Paraplegia 15 (SPG15)
    Full story
  • Alexion Cutting 600 Jobs And Moving Headquarters In Major Shakeup

    Sep 12, 2017, 09:41 AM by Michael Croft
    STAT | Alexion, once one of biotech's biggest success stories, is eliminating 20% of its global workforce as it struggles to map out a brighter future.
    Full story
  • «
  • 291
  • 292
  • 293
  • 294 (current)
  • 295
  • 296
  • 297
  • 298
  • 299
  • 300
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy